Publications by authors named "Lars Hanker"

Claim this Profile
T
The Role of the Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 in Breast Cancer Pathophysiology.
Lena Habenicht, Nourhan Hassan, Nancy A Espinoza-Sànchez, Jessica Oyie Sousa Onyeisi, Balázs Győrffy, Lars Hanker

Cells· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study.
Anna Jaeger, Monika Hampl, Katharina Prieske, Christine Eulenburg, Juliane Reichenbach, Lars Hanker

Gynecol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group - Real-world observations.
Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, Markus Kerkmann, Lars Hanker

Eur J Surg Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Value of the Hedgehog Signaling Pathway in Ovarian Cancer.
Noor D Salman, Lars C Hanker, Balázs Győrffy, Áron Bartha, Louisa Proppe

Int J Mol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer".
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, René dePont Christensen, Zoltán Novák, Lars C Hanker

Future Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimally invasive compared to open surgery in patients with low-risk cervical cancer following simple hysterectomy: An exploratory analysis from the Gynegologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial.
Marie Plante, Sven Mahner, Alexandra Sebastianelli, Paul Bessette, Eric Lambaudie, Lars Hanker

Int J Gynecol Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progression.
Jonathan Krell, Danielle Shaw, John McGrane, Andreas Hartkopf, Ana Herrero, Lars Hanker

Future Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.
Janice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson, Vanessa Samouëlian, Eric Lambaudie, Lars Hanker

J Gynecol Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease.
Dhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, Anna DeFazio, Marjorie J Riggan, Lars Hanker

NPJ Genom Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latissimus dorsi flap for breast reconstruction: a large single-institution evaluation of surgical outcome and complications.
Maggie Banys-Paluchowski, Laura Brus, Natalia Krawczyk, Sophie Valeria Kopperschmidt, Maria Luisa Gasparri, Lars Hanker

Arch Gynecol Obstet· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary ovarian leiomyoma: a rare ovarian tumour.
Mascha Pervan, Michael Gembicki, Henriette Princk, Achim Rody, Lars Hanker

Arch Gynecol Obstet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group.
Pauline Wimberger, Jacobus Pfisterer, Andreas du Bois, Felix Hilpert, Markus Kerkmann, Lars Hanker

Int J Gynecol Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, René dePont Christensen, Zoltán Novák, Lars C Hanker

N Engl J Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorangicin A Is Active against in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment.
Simon Graspeuntner, Katharina Koethke, Celeste Scholz, Lea Semmler, Mariia Lupatsii, Lars C Hanker

Antibiotics (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Treatment Practices and Prognostic Factors in Early-Stage Ovarian Cancer-An Analysis of the NOGGO/JAGO.
Sabine Heublein, Joanna Baum, Anna Jaeger, Donata Grimm-Glang, Julia Olthoff, Lars Hanker

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.
Jacobus Pfisterer, Florence Joly, Gunnar Kristensen, Joern Rau, Sven Mahner, Lars C Hanker

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).
Eva Roser, Philipp Harter, Dario Zocholl, Dominik Denschlag, Radoslav Chekerov, Lars Hanker

Int J Gynecol Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant.
Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer, Kati Erdmann, Susanne Füssel, Lars Hanker

Clin Cancer Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial.
Viktor Grünwald, Daniel Pink, Gerlinde Egerer, Enrico Schalk, Marinela Augustin, Lars C Hanker

Cancers (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lymphadenectomy on short- and long-term complications in patients with endometrial cancer.
Louisa Proppe, Ibrahim Alkatout, Ricarda Koch, Sascha Baum, Christos Kotanidis, Lars C Hanker

Arch Gynecol Obstet· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robotic surgery in gynecology: is the future already here?
Georgios Gitas, Lars Hanker, Achim Rody, Johannes Ackermann, Ibrahim Alkatout

Minim Invasive Ther Allied Technol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraoperative Ultrasound-Guided Excision of Non-Palpable and Palpable Breast Cancer: Systematic Review and Meta-Analysis.
Maggie Banys-Paluchowski, Isabel T Rubio, Güldeniz Karadeniz Cakmak, Antonio Esgueva, Natalia Krawczyk, Lars Hanker

Ultraschall Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies.
Natalia Krawczyk, Tanja Fehm, Eugen Ruckhaeberle, Laura Brus, Valeria Kopperschmidt, Lars Hanker

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer.
Konstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, Kathrin Möllenhoff, Klaus Baumann, Lars Hanker

J Natl Cancer Inst· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study.
Linn Woelber, Monika Hampl, Christine Zu Eulenburg, Katharina Prieske, Johanna Hambrecht, Lars Hanker

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis